skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > sphingolipid > glycosphingolipid > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))

اصطلاح مرجح

alpha-neuac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:1(4e))  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • -1

فرمول

  • C62H105N3O36R

والد-عملکردی دارد

جرم

  • 1468.498

جرم تک‌ایزوتوپی

  • 1467.64778

اسمایلٓ

  • O[C@H]1[C@H](O[C@H]([C@@H]([C@H]1O[C@]2(O[C@]([C@@H]([C@H](C2)O)NC(C)=O)([C@@H]([C@H](O)CO)O)[H])C([O-])=O)O)O[C@@H]3[C@H]([C@@H](O[C@@H]([C@@H]3O)CO)O[C@H]4[C@H]([C@H](O[C@H](O[C@H]5[C@H]([C@H](O[C@@H](O[C@@H]6[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]6O)O)CO)[C@@H]5O)CO)O)[C@@H]4O)CO)O)NC(C)=O)CO

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-iGb4Cer(d18:1(4E))
  • isogloboside NeuAcGal-iGb4Cer (d18:1(4E))
  • iso-NeuAc-Gal-Gb4-Cer(d18:1(4E))
  • N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
  • N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-sphing-4E-enine

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141103

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD